Last A$85.88 AUD
Change Today +0.60 / 0.70%
Volume 2.7M
As of 6:50 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew Cuthbertson BMedSci, MBBS, Ph.D.

Chief Scientific officer and Director of R&D, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 2 board members in 1 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Andrew Cuthbertson, BMedSci, MBBS, Ph.D., serves as Chief Scientific Officer and Research & Development Director of CSL Behring LLC. Dr. Cuthbertson manages an internal R&D budget of over $350m, and a global Research & Development organisation of 800 scientists. He is responsible for crafting the global R&D strategy for CSL. Dr. Cuthbertson joined in CSL Behring LLC 1997 as Research Director. Dr. Cuthbertson spent five years doing molecular biology research as a ...

Read Full Background

Corporate Headquarters*

45 Poplar Road
Parkville, Victoria 3052


Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

Board Members Memberships*



There is no Education data available.

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,248,117

Stock Options*

Restricted Stock Awards$424,102
Long Term Incentive Plan$223,766
All Other Compensation$84,591
Exercised Options6,070
Unexercisable Options43,510
Total Number of Options49,580

Total Compensation*

Total Annual Cash Compensation$1,332,708
Total Short Term Compensation$1,248,117
Other Long Term Compensation$508,693
Total Calculated Compensation$2,028,296
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$85.88 AUD +0.60


Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
Flemming Ornskov M.D., MBA, MPHManaging Director, Chief Executive Officer and Director
Shire plc
Victor Grifols Roura Chairman, Chief Executive Officer, President, Managing Director and Member of Appointments & Remuneration Committee
Grifols, S.A.
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at